Submitted by Anonymous (not verified) on 4 March 2026 - 16:13
Human medicines European public assessment report (EPAR): Eylea, aflibercept, Date of authorisation: 21/11/2012, Revision: 39, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Eylea, aflibercept, Date of authorisation: 21/11/2012, Revision: 39, Status: Authorised